Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population-Reference-Cited by-同舟云学术

Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population

Published:2021-09-21 Issue:12 Volume:144 Page:916-929
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Bergström Göran¹²^ORCID,Persson Margaretha³⁴^ORCID,Adiels Martin⁵^ORCID,Björnson Elias¹,Bonander Carl⁵^ORCID,Ahlström Håkan⁶,Alfredsson Joakim⁷⁸,Angerås Oskar¹⁹,Berglund Göran³,Blomberg Anders¹⁰,Brandberg John¹¹¹²,Börjesson Mats¹³¹⁴¹⁵^ORCID,Cederlund Kerstin¹⁶,de Faire Ulf¹⁷^ORCID,Duvernoy Olov⁶,Ekblom Örjan¹⁸^ORCID,Engström Gunnar³^ORCID,Engvall Jan E.⁸¹⁹²⁰^ORCID,Fagman Erika¹¹¹²^ORCID,Eriksson Mats²¹^ORCID,Erlinge David²²,Fagerberg Björn¹¹⁵^ORCID,Flinck Agneta¹¹¹²,Gonçalves Isabel²³,Hagström Emil²⁴²⁵,Hjelmgren Ola¹²^ORCID,Lind Lars²⁶^ORCID,Lindberg Eva²⁷,Lindqvist Per²⁸,Ljungberg Johan¹⁰,Magnusson Martin³²⁹³⁰³¹,Mannila Maria³²,Markstad Hanna³³³⁴,Mohammad Moman A.²²^ORCID,Nystrom Fredrik H.⁸^ORCID,Ostenfeld Ellen³⁵^ORCID,Persson Anders⁸³⁶²⁰^ORCID,Rosengren Annika¹¹⁵^ORCID,Sandström Anette¹⁰^ORCID,Själander Anders¹⁰^ORCID,Sköld Magnus C.³⁷³⁸,Sundström Johan²⁶³⁹^ORCID,Swahn Eva⁷⁸,Söderberg Stefan¹⁰^ORCID,Torén Kjell⁴⁰¹⁵,Östgren Carl Johan⁸²⁰^ORCID,Jernberg Tomas⁴¹^ORCID

Affiliation:

1. Department of Molecular and Clinical Medicine (G. Bergström, E.B., O.A., B.F., O.H., A.R.), University of Gothenburg, Sweden.

2. Departments of Clinical Physiology (G. Bergström, O.H.), Region Västra Götaland, Gothenburg, Sweden.

3. Department of Clinical Sciences (M.P., G. Berglund, G.E., M. Magnusson), Lund University, Malmö, Sweden.

4. Departments of Internal Medicine (M.P.), Skåne University Hospital, Malmö, Sweden.

5. Sahlgrenska Academy, and School of Public Health and Community Medicine, Institute of Medicine (M.A., C.B.), University of Gothenburg, Sweden.

6. Section of Radiology, Department of Surgical Sciences (H.A., O.D.), Uppsala University, Sweden.

7. Departments of Cardiology (J.A., E.S.), Linköping University, Sweden.

8. Health, Medicine and Caring Sciences (J.A., E.S., J.E.E., F.H.N., C.J.Ö., A.P.), Linköping University, Sweden.

9. Cardiology (O.A.), Region Västra Götaland, Gothenburg, Sweden.

10. Department of Public Health and Clinical Medicine, Medicine and Heart Centre (A.B., J.L., A. Sandström, A. Själander, S.S.), Umeå University, Sweden.

11. Department of Radiology, Institute of Clinical Sciences (J.B., E.F., A.F.), University of Gothenburg, Sweden.

12. Radiology (J.B., E.F., A.F.), Region Västra Götaland, Gothenburg, Sweden.

13. Institute of Medicine (M.B.), University of Gothenburg, Sweden.

14. Center for Health and Performance (M.B.), University of Gothenburg, Sweden.

15. Sahlgrenska University Hospital (M.B., B.F., A.R., K.T.), Region Västra Götaland, Gothenburg, Sweden.

16. Department of Clinical Science, Intervention and Technology (K.C.), Karolinska Institutet, Stockholm, Sweden.

17. Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine (U.d.F.), Karolinska Institutet, Stockholm, Sweden.

18. Department of Physical Activity and Health, The Swedish School of Sport and Health Sciences (GIH), Stockholm, Sweden (Ö.E.).

19. Clinical Physiology (J.E.E.), Linköping University, Sweden.

20. CMIV, Centre of Medical Image Science and Visualization (J.E.E., A.P., C.J.Ö.), Linköping University, Sweden.

21. Department of Endocrinology, Metabolism & Diabetes and Clinical Research Center, Karolinska University Hospital Huddinge, Stockholm, Sweden (M.E.).

22. Department of Clinical Sciences Lund, Cardiology, Lund University and Skåne University Hospital, Lund, Sweden (D.E., M.A.M.).

23. Department of Clinical Sciences Malmö (I.G.), Lund University and Skåne University Hospital, Lund, Sweden.

24. Cardiology (E.H.), Uppsala University, Sweden.

25. Department of Medical Sciences, and Uppsala Clinical Research Center (E.H.), Uppsala University, Sweden.

26. Clinical Epidemiology (L.L., J.S.), Uppsala University, Sweden.

27. Respiratory, Allergy and Sleep Research (E.L.), Uppsala University, Sweden.

28. Department of Surgical and Perioperative Sciences (P.L.), Umeå University, Sweden.

29. Cardiology (M. Magnusson), Skåne University Hospital, Malmö, Sweden.

30. Wallenberg Center for Molecular Medicine, Lund University, Sweden (M. Magnusson).

31. North-West University, Hypertension in Africa Research Team (HART), Potchefstroom, South Africa (M. Magnusson).

32. Heart and Vascular Theme, Department of Cardiology, and Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden (M. Mannila).

33. Experimental Cardiovascular Research, Clinical Research Center, Clinical Sciences Malmö (H.M.), Lund University, Malmö, Sweden.

34. Center for Medical Imaging and Physiology (H.M.), Lund University and Skåne University Hospital, Lund, Sweden.

35. Department of Clinical Sciences Lund, Clinical Physiology (E.O.), Lund University and Skåne University Hospital, Lund, Sweden.

36. Radiology (A.P.), Linköping University, Sweden.

37. Respiratory Medicine Unit, Department of Medicine Solna and Center for Molecular Medicine (M.C.S.), Karolinska Institutet, Stockholm, Sweden.

38. Department of Respiratory Medicine and Allergy, Karolinska University Hospital Solna, Stockholm, Sweden (M.C.S.).

39. The George Institute for Global Health, University of New South Wales, Sydney, Australia (J.S.).

40. Occupational and Environmental Medicine/School of Public Health and Community Medicine (K.T.), University of Gothenburg, Sweden.

41. Department of Clinical Sciences, Danderyd University Hospital (T.J.), Karolinska Institutet, Stockholm, Sweden.

Abstract

Background: Early detection of coronary atherosclerosis using coronary computed tomography angiography (CCTA), in addition to coronary artery calcification (CAC) scoring, may help inform prevention strategies. We used CCTA to determine the prevalence, severity, and characteristics of coronary atherosclerosis and its association with CAC scores in a general population. Methods: We recruited 30 154 randomly invited individuals age 50 to 64 years to SCAPIS (the Swedish Cardiopulmonary Bioimage Study). The study includes individuals without known coronary heart disease (ie, no previous myocardial infarctions or cardiac procedures) and with high-quality results from CCTA and CAC imaging performed using dedicated dual-source CT scanners. Noncontrast images were scored for CAC. CCTA images were visually read and scored for coronary atherosclerosis per segment (defined as no atherosclerosis, 1% to 49% stenosis, or ≥50% stenosis). External validity of prevalence estimates was evaluated using inverse probability for participation weighting and Swedish register data. Results: In total, 25 182 individuals without known coronary heart disease were included (50.6% women). Any CCTA-detected atherosclerosis was found in 42.1%; any significant stenosis (≥50%) in 5.2%; left main, proximal left anterior descending artery, or 3-vessel disease in 1.9%; and any noncalcified plaques in 8.3% of this population. Onset of atherosclerosis was delayed on average by 10 years in women. Atherosclerosis was more prevalent in older individuals and predominantly found in the proximal left anterior descending artery. Prevalence of CCTA-detected atherosclerosis increased with increasing CAC scores. Among those with a CAC score >400, all had atherosclerosis and 45.7% had significant stenosis. In those with 0 CAC, 5.5% had atherosclerosis and 0.4% had significant stenosis. In participants with 0 CAC and intermediate 10-year risk of atherosclerotic cardiovascular disease according to the pooled cohort equation, 9.2% had CCTA-verified atherosclerosis. Prevalence estimates had excellent external validity and changed marginally when adjusted to the age-matched Swedish background population. Conclusions: Using CCTA in a large, random sample of the general population without established disease, we showed that silent coronary atherosclerosis is common in this population. High CAC scores convey a significant probability of substantial stenosis, and 0 CAC does not exclude atherosclerosis, particularly in those at higher baseline risk.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055340

Reference52 articles.

1. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002

2. The Swedish National Board of Health and Welfare. Health and Medical Care: Statistics on Myocardial Infarctions 2019. The Swedish National Board of Health and Welfare; 2020:1–5. https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/artikelkatalog/statistik/2020-12-7062.pdf

3. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease

4. Coronary Risk Factors and Plaque Morphology in Men with Coronary Disease Who Died Suddenly

5. A Prospective Natural-History Study of Coronary Atherosclerosis

Cited by 214 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Skp2 degradation with troxerutin decreases neointima formation;European Journal of Pharmacology;2024-11

2. Low-density lipoprotein-cholesterol and subclinical coronary atherosclerosis in a middle-aged asymptomatic U.S. population: The Miami Heart Study at Baptist Health South Florida;Atherosclerosis;2024-10

3. The predictive value of coronary artery calcium score combined with traditional risk factors for obstructive coronary heart disease in young people;BMC Cardiovascular Disorders;2024-09-10

4. Anxiety and disease awareness in individuals with heredity for abdominal aortic aneurysm;Journal of Medical Screening;2024-09-09

5. Non-Coding RNA Involved in the Pathogenesis of Atherosclerosis—A Narrative Review;Diagnostics;2024-09-07